Global Obesity Management Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 06-Oct-2022
No. of pages: 98
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Obesity Management companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Obesity Management market. Further, it explains the major drivers and regional dynamics of the global Obesity Management market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Roche

- GlaxoSmithKline

- Orexigen Therapeutics

- Arena Pharmaceuticals

- VIVUS

- Novo Nordisk

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Obesity Management Segment by Type

- Drug

- Surgery

Obesity Management Segment by Application

- Hospitals

- Speciality Clinics

- Ambulatory Surgical Centres

- Retail Pharmacies

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Obesity Management market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Obesity Management market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Obesity Management, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Obesity Management, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Obesity Management revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Obesity Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Obesity Management revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, GlaxoSmithKline, Orexigen Therapeutics, Arena Pharmaceuticals, VIVUS and Novo Nordisk, etc.

Global Obesity Management Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Management Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Obesity Management Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Obesity Management Market Size (2017-2028)
2.2 Obesity Management Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Obesity Management Market Size by Region (2017-2022)
2.4 Global Obesity Management Market Size Forecast by Region (2023-2028)
2.5 Global Top Obesity Management Countries Ranking by Market Size
3 Obesity Management Competitive by Company
3.1 Global Obesity Management Revenue by Players
3.1.1 Global Obesity Management Revenue by Players (2017-2022)
3.1.2 Global Obesity Management Market Share by Players (2017-2022)
3.2 Global Obesity Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Obesity Management Revenue
3.4 Global Obesity Management Market Concentration Ratio
3.4.1 Global Obesity Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Management Revenue in 2021
3.5 Global Obesity Management Key Players Head office and Area Served
3.6 Key Players Obesity Management Product Solution and Service
3.7 Date of Enter into Obesity Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Obesity Management Breakdown Data by Type
4.1 Global Obesity Management Historic Revenue by Type (2017-2022)
4.2 Global Obesity Management Forecasted Revenue by Type (2023-2028)
5 Global Obesity Management Breakdown Data by Application
5.1 Global Obesity Management Historic Market Size by Application (2017-2022)
5.2 Global Obesity Management Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Obesity Management Revenue by Company (2020-2022)
6.2 North America Obesity Management Revenue by Type (2017-2028)
6.3 North America Obesity Management Revenue by Application (2017-2028)
6.4 North America Obesity Management Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Obesity Management Revenue by Company (2020-2022)
7.2 Europe Obesity Management Revenue by Type (2017-2028)
7.3 Europe Obesity Management Revenue by Application (2017-2028)
7.4 Europe Obesity Management Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Obesity Management Revenue by Company (2020-2022)
8.2 Asia Pacific Obesity Management Revenue by Type (2017-2028)
8.3 Asia Pacific Obesity Management Revenue by Application (2017-2028)
8.4 Asia Pacific Obesity Management Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Obesity Management Revenue by Company (2020-2022)
9.2 Latin America Obesity Management Revenue by Type (2017-2028)
9.3 Latin America Obesity Management Revenue by Application (2017-2028)
9.4 Latin America Obesity Management Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Obesity Management Revenue by Company (2020-2022)
10.2 Middle East and Africa Obesity Management Revenue by Type (2017-2028)
10.3 Middle East and Africa Obesity Management Revenue by Application (2017-2028)
10.4 Middle East and Africa Obesity Management Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Obesity Management Products and Services
11.1.4 Roche Obesity Management Revenue in Obesity Management Business (2017-2022)
11.1.5 Roche Obesity Management SWOT Analysis
11.1.6 Roche Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Obesity Management Products and Services
11.2.4 GlaxoSmithKline Obesity Management Revenue in Obesity Management Business (2017-2022)
11.2.5 GlaxoSmithKline Obesity Management SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Orexigen Therapeutics
11.3.1 Orexigen Therapeutics Company Details
11.3.2 Orexigen Therapeutics Business Overview
11.3.3 Orexigen Therapeutics Obesity Management Products and Services
11.3.4 Orexigen Therapeutics Obesity Management Revenue in Obesity Management Business (2017-2022)
11.3.5 Orexigen Therapeutics Obesity Management SWOT Analysis
11.3.6 Orexigen Therapeutics Recent Developments
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Obesity Management Products and Services
11.4.4 Arena Pharmaceuticals Obesity Management Revenue in Obesity Management Business (2017-2022)
11.4.5 Arena Pharmaceuticals Obesity Management SWOT Analysis
11.4.6 Arena Pharmaceuticals Recent Developments
11.5 VIVUS
11.5.1 VIVUS Company Details
11.5.2 VIVUS Business Overview
11.5.3 VIVUS Obesity Management Products and Services
11.5.4 VIVUS Obesity Management Revenue in Obesity Management Business (2017-2022)
11.5.5 VIVUS Obesity Management SWOT Analysis
11.5.6 VIVUS Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Obesity Management Products and Services
11.6.4 Novo Nordisk Obesity Management Revenue in Obesity Management Business (2017-2022)
11.6.5 Novo Nordisk Obesity Management SWOT Analysis
11.6.6 Novo Nordisk Recent Developments
12 Obesity Management Market Dynamics
12.1 Obesity Management Market Trends
12.2 Obesity Management Market Drivers
12.3 Obesity Management Market Challenges
12.4 Obesity Management Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Obesity Management Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drug
Table 3. Key Players of Surgery
Table 4. Global Obesity Management Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Obesity Management Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Obesity Management Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Obesity Management Revenue Market Share by Region (2017-2022)
Table 8. Global Obesity Management Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Obesity Management Market Share by Players (2017-2022)
Table 10. Global Top Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Management as of 2021)
Table 11. Ranking of Global Top Obesity Management Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Obesity Management Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Obesity Management Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Obesity Management Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Obesity Management Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Obesity Management Revenue Market Share by Type (2017-2022)
Table 19. Global Obesity Management Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Obesity Management Revenue Market Share by Type (2023-2028)
Table 21. Global Obesity Management Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Obesity Management Revenue Market Share by Application (2017-2022)
Table 23. Global Obesity Management Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Obesity Management Revenue Market Share by Application (2023-2028)
Table 25. North America Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Obesity Management Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Obesity Management Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Obesity Management Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Obesity Management Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Obesity Management Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Obesity Management Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Obesity Management Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Obesity Management Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Obesity Management Revenue by Country (2023-2028) & (US$ Million)
Table 60. Roche Company Details
Table 61. Roche Business Overview
Table 62. Roche Obesity Management Product and Services
Table 63. Roche Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 64. Roche Obesity Management SWOT Analysis
Table 65. Roche Recent Developments
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Obesity Management Product and Services
Table 69. GlaxoSmithKline Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 70. GlaxoSmithKline Obesity Management SWOT Analysis
Table 71. GlaxoSmithKline Recent Developments
Table 72. Orexigen Therapeutics Company Details
Table 73. Orexigen Therapeutics Business Overview
Table 74. Orexigen Therapeutics Obesity Management Product and Services
Table 75. Orexigen Therapeutics Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 76. Orexigen Therapeutics Obesity Management SWOT Analysis
Table 77. Orexigen Therapeutics Recent Developments
Table 78. Arena Pharmaceuticals Company Details
Table 79. Arena Pharmaceuticals Business Overview
Table 80. Arena Pharmaceuticals Obesity Management Product and Services
Table 81. Arena Pharmaceuticals Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 82. Arena Pharmaceuticals Obesity Management SWOT Analysis
Table 83. Arena Pharmaceuticals Recent Developments
Table 84. VIVUS Company Details
Table 85. VIVUS Business Overview
Table 86. VIVUS Obesity Management Product and Services
Table 87. VIVUS Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 88. VIVUS Obesity Management SWOT Analysis
Table 89. VIVUS Recent Developments
Table 90. Novo Nordisk Company Details
Table 91. Novo Nordisk Business Overview
Table 92. Novo Nordisk Obesity Management Product and Services
Table 93. Novo Nordisk Obesity Management Revenue in Obesity Management Business (2017-2022) & (US$ Million)
Table 94. Novo Nordisk Obesity Management SWOT Analysis
Table 95. Novo Nordisk Recent Developments
Table 96. Obesity Management Market Trends
Table 97. Obesity Management Market Drivers
Table 98. Obesity Management Market Challenges
Table 99. Obesity Management Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obesity Management Sales Market Share by Type: 2021 VS 2028
Figure 2. Drug Features
Figure 3. Surgery Features
Figure 4. Global Obesity Management Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Speciality Clinics Case Studies
Figure 7. Ambulatory Surgical Centres Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Obesity Management Report Years Considered
Figure 10. Global Obesity Management Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Obesity Management Market Size 2017-2028 (US$ Million)
Figure 12. Global Obesity Management Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Obesity Management Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Obesity Management Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Obesity Management Market Share by Players in 2021
Figure 16. Global Top Obesity Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Management as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Obesity Management Revenue in 2021
Figure 18. North America Obesity Management Revenue Market Share by Company in 2021
Figure 19. North America Obesity Management Revenue Market Share by Type (2017-2028)
Figure 20. North America Obesity Management Revenue Market Share by Application (2017-2028)
Figure 21. North America Obesity Management Revenue Share by Country (2017-2028)
Figure 22. United States Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Obesity Management Revenue Market Share by Company in 2021
Figure 25. Europe Obesity Management Revenue Market Share by Type (2017-2028)
Figure 26. Europe Obesity Management Revenue Market Share by Application (2017-2028)
Figure 27. Europe Obesity Management Revenue Share by Country (2017-2028)
Figure 28. Germany Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 29. France Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Obesity Management Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Obesity Management Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Obesity Management Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Obesity Management Revenue Share by Region (2017-2028)
Figure 37. China Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 40. India Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 46. Latin America Obesity Management Revenue Market Share by Company in 2021
Figure 47. Latin America Obesity Management Revenue Market Share by Type (2017-2028)
Figure 48. Latin America Obesity Management Revenue Market Share by Application (2017-2028)
Figure 49. Latin America Obesity Management Revenue Share by Country (2017-2028)
Figure 50. Mexico Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 51. Brazil Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 52. Argentina Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Obesity Management Revenue Market Share by Company in 2021
Figure 54. Middle East and Africa Obesity Management Revenue Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Obesity Management Revenue Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Obesity Management Revenue Share by Country (2017-2028)
Figure 57. Turkey Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 59. UAE Obesity Management Revenue (2017-2028) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 62. Orexigen Therapeutics Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 64. VIVUS Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 65. Novo Nordisk Revenue Growth Rate in Obesity Management Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs